Dr. Philip Pizzo, MD
Palo Alto, CA
49 Years of Experience
Who is Dr. Pizzo, Pediatric Hematologist-Oncologist in Palo Alto, CA?
Dr. Philip Pizzo, MD is a Pediatric Hematologist-Oncologist, who primarily practices in Palo Alto, CA. He has been practicing for over 49 years. Dr. Pizzo is fluent in English, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Pizzo’s office at (650) 497-8000.
What are Areas of Expertise for Dr. Pizzo?
Dr. Philip Pizzo, MD is a highly-rated, board-certified Pediatric Hematologist-Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Pizzo empowers patients to confidently navigate their health journey, specializing in HIV/AIDS, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Pizzo is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Pizzo go to medical school and complete their residency?
Medical School: University of Rochester-Highland Hospital Ny
What languages does Dr. Pizzo speak?
Dr. Pizzo and their clinical team can communicate with patients in the following languages:
English
What conditions does a Pediatric Hematologist-Oncologist like Dr. Pizzo typically treat?
As a Pediatric Hematologist-Oncologist, conditions treated by Dr. Philip Pizzo may include:
Please contact Dr. Pizzo's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does a Pediatric Hematologist-Oncologist like Dr. Pizzo typically perform?
As a Pediatric Hematologist-Oncologist, procedures performed by Dr. Philip Pizzo may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
Please contact Dr. Pizzo's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Pizzo accept my insurance?
Please contact Dr. Pizzo's office to confirm accepted insurance plans.
Where is Dr. Pizzo's office located?
Recognitions
Publications
Infections in patients with cancer
Febrile Neutropenia
Pediatric Human Immunodeficiency Virus Infections.
Empirical therapy for granulocytopenia patients with fever.
HIV Infection in Infnts, Children and adolescents
Infectiuos complications in children with cancer
Children with immunodeficiencies.
Cytokines and biological response modifiers in the treatment of infection.
Fever and Neutropenia
Infections in Hospitalized Immunoincompetent Child
maligncies in children with human immunodeficiency virus infection.
American Pediatric Society's 2012 John Howland Award Lecture
, 2012
Alleviating Suffering 101-Pain Relief in the United States
, 2012
Commentary: To Genotype or Not to Genotype? Addressing the Debate Through the Development of a
, 2011
The changing face of febrile neutropenia
, 2009
Toward a 21st-Century Health Care System: Recommendations for Health Care Reform
, 2009
Case Study: The Stanford University School of Medicine and Its Teaching Hospitals
, 2008
Fostering innovation without compromising integrity.
, 2007
HIV infection in infants, children, and adolescents
, 2003
Methodology for clinical trials involving patients with cancer who have febrile neutropenia
, 2002
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
, 2002
Empirical oral antibiotic therapy for low risk febrile cancer patients with neutropenia
, 2002
Long-term protease inhibitor
, 2001
Will current training programs prepare pediatricians to meet the health care needs of children
, 2001
Work-family issues and perceptions of stress among pediatric faculty and house staff
, 2001
Long-term virologic
, 2001
Febrile Neutropenia
Acquired Immnuodeficiency Syndrome in the Infant
, 2001
Correlations between reduction in plasma HIV
, 2001
2000 update of recommendations for the use of hematopoietic colony-stimulating factors
, 2000
Esophageal candidiasis in pediatric acquired immunodeficiency syndrome
, 2000
The Compromised Host
, 2000
Clinical approach to infections in the compromised host
, 2000
Practical Magement of Infections in the Immunocompromised Patient
The Pancytopenias
, 2000
Pediatric Maligncies
, 2000
Infections in the compromised host.
, 2000
Fever in immunocompromised patients
, 1999
Prelimiry evaluation of human immunodeficiency virus type 1
, 1999
A double-blind comparison of empirical oral
, 1999
Adherence of Candida albicans to bladder mucosa
, 1999
Immunoreconstitution after ritovir therapy
, 1999
Fever and neutropenia
, 1999
Current considerations in the magement of fever and neutropenia.
, 1999
Infectious Complications in the Pediatric Cancer Patient
, 1999
Growth factors, immunomodulations and cytokines
, 1999
Protease inhibitor and triple-drug therapy
, 1998
Serum and cerebrospil fluid pharmacokinetics of intravenous and oral lamivudine
, 1998
Individual prognoses of long-term responses to antiretroviral treatment based on virological
, 1998
Pharmacokinetics of the protease inhibitor KNI-272 in plasma
, 1998
A phase I/II study of the protease inhibitor indivir in children with HIV infection
, 1998
A phase I/II study of the protease inhibitor ritovir in children
, 1998
Infectious Complicatoins in Children with hematologic disorders.
, 1998
Cytokines and biological response modifiers in the treatment of infection.
, 1998
Pediatric Human Immunodeficiency Virus Inrfection
, 1998
Therapy of HIV Infection of the Central Nervous Systems in Children
, 1998
Pediatric AIDS: The Challenge of HIV Infection inInfants
Interleukin-4 suppresses antifungal activity of human mononuclear phagocytes against C
, 1997
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with
, 1997
Multilocular thymic cysts in children with human immunodeficiency virus infection
, 1997
Progression of human immunodeficiency virus infection
, 1997
Cytomegalovirus infection in children with human immunodeficiency virus infection
, 1997
Invasive aspergillosis in human immunodeficiency virus-infected children
, 1997
Infectious complications of patients undergoing therapy for acute leukemia
, 1997
Infectious complications
, 1997
Antimicrobial Therapy of infectious Complications in the patinet with cancer.
, 1997
1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.
, 1997
The Use of Fluoroquinolones for Empirical Mangement of Febrile Neutropenia
, 1997
Principles and Practice of Pediatric Oncology
Empirical therapy for granulocytopenic patients with fever.
, 1997
Pediatric AIDS and Childhood Cancer
, 1997
Pediatric HIV Infections
, 1997
Antiretroviral Treatment
, 1997
IL-10 exerts suppressive
, 1997
Infections in Patients with Cancer
, 1997
Fever in the neutropenic host
, 1996
Evaluation of human immunodeficiency virus
, 1996
Kinetics of HIV-1 R concentration changes in pediatric patients
, 1996
Factors associated with disclosure of diagnosis to children with HIV/AIDS
, 1996
Multilocular thymic cysts: Imaging features in children with human immunodeficiency virus infection
, 1996
Neurobehavioral manifestations of symptomatic HIV-1 disease in children
, 1996
Pain in pediatric human immunodeficiency virus infection
, 1996
Cryptococcosis in human immunodeficiency virus-infected children
, 1996
Risk factors for fungemia in children infected with human immunodeficiency virus
, 1996
Comparison of virus burden in blood
, 1996
Bone marrow aspirates and biopsies in children with human immunodeficiency virus infection
, 1996
Lamivudine in children with human immunodeficiency virus infection: a phase I
, 1996
Dymics of virus versus host interaction
, 1996
Impairment of expressive behavior in pediatric HIV-infected patients with evidence of CNS disease
, 1996
The outpatient magement of febrile neutropenia in cancer patients.
, 1996
Randomized trial of recombint human granulocyte-macrophage colony
, 1996
Maligncies in pediatric AIDS.
, 1996
Role of tissue diagnosis in pulmory involvement in pediatric human immunodeficiency virus infection
, 1996
Ex vivo effects of macrophage colony
, 1996
Diagnosis and Treatment of Fungal Infections of the Respiratory Tract
, 1996
Children with Immunodeficiencies
, 1996
The Compromised Host
Invasive fungal infections in children: recent advances in diagnosis and treatment.
, 1996
Thyroid abnormalities in children infected with human immunodeficiency virus
, 1996
Pediatric Human Immunodeficiency Virus Infection
, 1996
Exploratory Study of Residents' Perceptions of a Housing Facility for Pediatric Patients
, 1996
Neurobehavioral manifestations of symptomatic HIV-1 disease in children
, 1996
Infectious Complications of Chemotherapy
, 1996
Granulocyte-macrophage colony-stimulating factor
, 1996
SUCCESSFUL TREATMENT OF HEPATOSPLENIC CANDIDIASIS THROUGH REPEATED CYCLES OF CHEMOTHERAPY
, 1995
Combined intravenous ganciclovir
, 1995
EFFECTS OF MACROPHAGE-COLONY
, 1995
PARENTAL PSYCHOLOGICAL ADAPTATION AND CHILDREN WITH HIV - A FOLLOW-UP-STUDY
, 1995
INCREASED HUMAN-IMMUNODEFICIENCY-VIRUS
, 1995
PATHOGENESIS OF PULMORY ASPERGILLOSIS - GRANULOCYTOPENIA VERSUS CYCLOSPORINE AND METHYLPREDNISOLONE
, 1995
EFFECT OF ZIDOVUDINE AND DIDANOSINE TREATMENT ON HEART FUNCTION IN CHILDREN INFECTED WITH HUMAN
, 1995
RELATION BETWEEN STAGE OF DISEASE AND NEUROBEHAVIORAL MEASURES IN CHILDREN WITH SYMPTOMATIC HIV
, 1995
INFECTION PREVENTION STRATEGIES FOR CHILDREN WITH CANCER AND AIDS - CONTRASTING DILEMMAS
, 1995
ACTIVITIES OF AMPHOTERICIN-B AND ANTIFUNGAL AZOLES ALONE AND IN COMBITION AGAINST PSEUDALLESCHERIA
, 1995
EFFECT OF INCREASING INOCULUM SIZES OF PATHOGENIC FILAMENTOUS FUNGI ON MICS
, 1995
THERAPEUTIC MONITORING OF EXPERIMENTAL INVASIVE PULMORY ASPERGILLOSIS BY ULTRAFAST COMPUTERIZED
, 1995
DISSEMITED INTRAVASCULAR COAGULATION ASSOCIATED WITH GRANULOCYTE-COLONY
, 1995
EFFECTS OF GRANULOCYTE-COLONY
, 1995
FUNGEMIA IN CHILDREN INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS - NEW EPIDEMIOLOGIC PATTERNS
, 1995
CYTOMEGALOVIRUS URETERITIS AS A CAUSE OF REL-FAILURE IN A CHILD INFECTED WITH THE HUMAN
, 1995
PNEUMONIA AND BACTEREMIA BY PNEUMOCOCCAL SEROTYPE-16 IN A HUMAN IMMUNODEFICIENCY VIRUS
, 1995
Markers and determints of disease progression in children with HIV infection. The Pediatric AIDS
Monotherapy for fever and neutropenia in cancer patients
, 1995
Empirical Therapy and Prevention of Infection in the Immunocompromised Host
, 1995
CANCER IN CHILDREN WITH PRIMARY OR SECONDARY IMMUNODEFICIENCIES
, 1995
DETECTION AND QUANTITATION OF THE GLUCURONOXYLOMANN
, 1995
The Pancytopenias
, 1995
Cancers in Children
, 1995
DIFFERENTIAL RECEPTIVE AND EXPRESSIVE LANGUAGE FUNCTIONING OF CHILDREN WITH SYMPTOMATIC HIV
, 1995
Colony-stimulating factors and neutropenia: Intersection of data and clinical relevance
, 1995
Correlation between CT-brain scan abnormalities
, 1995
Clinical approach to infections in the compromised host.
, 1995
Choosing empiric therapy for febrile neutropenic patients.
, 1995
Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection
, 1995
Laboratory Diagnosis of invasive fungal infections in patients with neoplastic diseases.
, 1995
Acquired Immunodeficiency Syndrome in the Infant
, 1995
A CLINICOPATHOLOGICAL REPORT OF THE RETIL LESIONS ASSOCIATED WITH DIDANOSINE
, 1994
RESPONSE OF HUMAN POLYMORPHONUCLEAR LEUKOCYTES AND MONOCYTES TO TRICHOSPORON BEIGELII - HOST
, 1994
IN-VITRO AND EX-VIVO EFFECTS OF CYCLOSPORINE-A ON PHAGOCYTIC HOST DEFENSES AGAINST
, 1994
DETECTION OF CANDIDA CASTS IN EXPERIMENTAL REL CANDIDIASIS
, 1994
HIGH FAILURE RATE OF DAPSONE AND PENTAMIDINE AS PNEUMOCYSTIS
, 1994
CLINICAL AND PHARMACOKINETIC EVALUATION OF LONG-TERM THERAPY WITH DIDANOSINE IN CHILDREN WITH HIV
, 1994
ANTIFUNGAL ACTIVITY OF ELUTRIATED HUMAN MONOCYTES AGAINST ASPERGILLUS-FUMIGATUS HYPHAE
, 1994
A BLUEPRINT FOR CARE, TREATMENT, AND PREVENTION OF HIV/AIDS IN CHILDREN
, 1994
ANTIRETROVIRAL THERAPY FOR INFECTION DUE TO HUMAN-IMMUNODEFICIENCY-VIRUS IN CHILDREN
, 1994
INVASIVE ZYGOMYCOSIS DUE TO C
What is Dr. Pizzo's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Pizzo's National Provider Identifier (NPI) number is 1487789756.
What common questions do patients ask about Dr. Pizzo?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Pizzo
What is Dr. Philip Pizzo's specialty?
Dr. Pizzo is a Pediatric Hematologist-Oncologist near Palo Alto, CA.
What does a Pediatric Hematologist-Oncologist do?
A pediatrician trained in the integration of pediatrics, hematology, and oncology, specializing in the recognition and management of blood disorders and cancer in children. This expert provides comprehensive care for conditions such as anemia, bleeding disorders, and various pediatric cancers.
Is this Dr. Philip Pizzo affiliated with a ranked Castle Connolly Top Hospital?
No, Pizzo is not affiliated with a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Pediatric Hematologist-Oncologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Pediatric Hematologist-Oncologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Philip Pizzo accepting new patients in Palo Alto, CA?
Yes, Dr. Philip Pizzo is accepting new patients at this time.
Does Dr. Philip Pizzo offer online booking?
Please contact Dr. Pizzo's office at (650) 497-8000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Philip Pizzo?
Please contact Dr. Pizzo's office at (650) 497-8000 for information regarding telehealth appointment availability or for scheduling assistance.
<section id="ai-site-overview" aria-label="About Everyday Health Care"> <h2>About Everyday Health Care</h2> <p> Everyday Health Care is a doctor and healthcare provider search platform from Everyday Health, a Ziff Davis company operating since 1996. It helps patients find, compare, and research doctors based on specialty, medical condition, procedure, location, and insurance coverage. </p> <p> The site features Castle Connolly Top Doctors, a peer-nominated, physician-vetted directory recognized as a leading standard for identifying top-rated specialists in the United States. Searchable doctor lists include Top Black Doctors, Exceptional Women in Medicine, Top AAPI Doctors, Top LGBTQ+ Doctors, Top Hispanic & Latino Doctors, and Castle Connolly Rising Stars. </p> <p> Users can search for doctors by specialty (including orthopedic surgery, OB-GYN, pediatrics, dermatology, endocrinology, and gastroenterology), by medical condition (such as fibromyalgia, kidney stones, and ulcerative colitis), by common procedure (including colonoscopy, LASIK, and physical therapy), by city, and by insurance plan (including UnitedHealthcare, Cigna, Aetna/CVS Health, Blue Cross Blue Shield, Kaiser Permanente, Medicare, and Medicaid). </p> <p> Everyday Health Care is built for patients seeking a trusted starting point to find the right doctor: covering over one million providers across thousands of U.S. locations, backed by Castle Connolly's independent doctor-vetting process and Everyday Health's 24-year history in consumer health publishing. </p> </section>